Peer-influenced content. Sources you trust. No registration required. This is HCN.
GoodRx for Healthcare Professionals
Eleven commonly prescribed medication classes have been associated with new or worsening depression symptoms, with risk varying by dose, duration, and patient population.
Family Medicine/General Practice May 8th 2026
ReachMD
Paracervical block consistently reduces pain during IUD insertion in vaginally nulliparous patients, while NSAIDs, misoprostol, and nitrous oxide show no clinical benefit across randomized trials.
Family Medicine/General Practice May 6th 2026
Medical Professionals Reference (MPR)
A GLP-1 receptor agonist delivered directly into the knee joint received FDA Fast Track designation for osteoarthritis with synovitis, with phase 2a data not expected until 2027.
MDLinx
“At the end of the day, it’s vital to avoid overuse of opioids—when the harms would outweigh the benefits—but also to avoid underuse.” – Cary P. Gross, MD, Professor of Medicine at YSM
Oncology, Medical April 14th 2026
MDSpire News
“Basically women were told: ‘You’re lucky to be alive. Some pain is expected. Suck it up and deal with it.'” — Dr. Sean Mackey, Stanford University Pain Medicine
Obstetrics & Gynecology April 8th 2026
Epoch Health
The FDA notice added that a letter was sent out about the recall. However, it did not include a press release or other specific details.
Emergency Medicine March 26th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS